---
layout: default
title: Faricimab
parent: Model Prediction Only (L5)
nav_order: 320
evidence_level: L5
indication_count: 0
---

# Faricimab
{: .fs-9 }

Evidence Level: **L5** | Predicted Indications: **0** 
{: .fs-6 .fw-300 }

---

## Table of Contents
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## Pharmacist Assessment Report

</div>

# Faricimab (DB15303): Insufficient Data to Complete Drug Repurposing Assessment

## One-Sentence Summary

Faricimab (DrugBank ID: DB15303) has **no original indication records** in this Evidence Pack and **no TxGNN prediction results**. Critical data including mechanism of action (MOA), safety information, and regulatory approval records are all missing; **this report currently cannot perform an effective drug repurposing assessment**.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | No data |
| Predicted New Indications | No prediction results |
| TxGNN Prediction Score | N/A |
| Evidence Level | N/A (No prediction data) |
| Market Status | Not marketed |
| Number of Regulatory Approvals | 0 |
| Recommended Decision | **Hold** |

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
This Evidence Pack contains multiple critical data gaps (see table below). The TxGNN prediction pipeline has not generated any candidate indications, and safety and regulatory information are also both missing. **We currently cannot initiate the drug repurposing assessment process.**

**Before proceeding to the next stage, the following data must be supplemented:**

| Priority | Gap ID | Missing Data | Remediation Method |
|----------|--------|--------------|-------------------|
| 🔴 Blocking | DG001 | Manufacturer package insert warnings and contraindications | Download and parse the package insert PDF from Health Canada website |
| 🟠 High | DG002 | Mechanism of action (MOA) | Query the DrugBank API (DB15303) |
| 🟠 High | — | Original approved indications (`original_indications` is empty) | Supplement approved indications from DrugBank / product package inserts |
| 🟠 High | — | TxGNN prediction results (`predicted_indications` is empty array) | Confirm FARICIMAB has been included in the prediction pipeline and re-run |
| 🟡 Medium | — | DDI data (query returned no results) | Confirm drug English name/aliases and re-query |

> **Note:** The results of this report are for research reference only and do not constitute medical advice. Any drug repurposing candidates must undergo clinical validation before application.

## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

